Steroid-induced osteoporosis in systemic lupus erythematosus

G. Cunnane, Nancy E Lane

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.

Original languageEnglish (US)
Pages (from-to)311-329
Number of pages19
JournalRheumatic Disease Clinics of North America
Volume26
Issue number2
StatePublished - 2000
Externally publishedYes

Fingerprint

Systemic Lupus Erythematosus
Osteoporosis
Steroids
Glucocorticoids
Bone and Bones
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Rheumatology

Cite this

Steroid-induced osteoporosis in systemic lupus erythematosus. / Cunnane, G.; Lane, Nancy E.

In: Rheumatic Disease Clinics of North America, Vol. 26, No. 2, 2000, p. 311-329.

Research output: Contribution to journalArticle

@article{606368e5fce941bfa0d71e46007b3253,
title = "Steroid-induced osteoporosis in systemic lupus erythematosus",
abstract = "The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.",
author = "G. Cunnane and Lane, {Nancy E}",
year = "2000",
language = "English (US)",
volume = "26",
pages = "311--329",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Steroid-induced osteoporosis in systemic lupus erythematosus

AU - Cunnane, G.

AU - Lane, Nancy E

PY - 2000

Y1 - 2000

N2 - The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.

AB - The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.

UR - http://www.scopus.com/inward/record.url?scp=0034086358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034086358&partnerID=8YFLogxK

M3 - Article

C2 - 10768214

AN - SCOPUS:0034086358

VL - 26

SP - 311

EP - 329

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 2

ER -